Helen Siobhan Marshall
Affiliation: University of Adelaide
- Uptake of varicella vaccine--a cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisationHelen Marshall
Department of Paediatrics, Women s and Children s Hospital, 72 King William Road, North Adelaide, SA 5006, Australia
Vaccine 23:5389-97. 2005..One year after inclusion of varicella vaccine in the Australian Standard Vaccination Schedule there is evidence of incomplete coverage in children in South Australia due to absence of government funding for vaccine provision...
- A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4-6 yearsH Marshall
Department of Paediatrics, Children s Youth and Women s Health Service and University of Adelaide, SA, Australia
Vaccine 24:6120-8. 2006..This combined DTPa-IPV vaccine has a similar reactogenicity profile to DTPa, is immunogenic when given as a booster dose at 4-6 years of age, and has no impact on the immunogenicity of a co-administered second dose of MMR vaccine...
- Ultrasound examination of extensive limb swelling reactions after diphtheria-tetanus-acellular pertussis or reduced-antigen content diphtheria-tetanus-acellular pertussis immunization in preschool-aged childrenHelen Siobhan Marshall
University Department of Paediatrics, Women s and Children s Hospital, 72 King William Rd, North Adelaide 5006, South Australia, Australia
Pediatrics 118:1501-9. 2006....
- A cross-sectional survey to assess community attitudes to introduction of Human papillomavirus vaccineHelen Marshall
Department of Paediatrics, Women s and Children s Hospital, School of Population Health and Clinical Practice, University of Adelaide, South Australia
Aust N Z J Public Health 31:235-42. 2007..The aim of this study was to assess community attitudes to the introduction of HPV vaccine in the State of South Australia...
- A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adultsHelen S Marshall
Vaccinology and Immunology Research Trials Unit, Women s and Children s Hospital and School of Paediatrics and Reproductive Health, University of Adelaide, North Adelaide, South Australia 5006, Australia
Vaccine 31:1569-75. 2013..A bivalent rLP2086 vaccine based on two factor H-binding proteins (fHBPs) has been developed to provide broad protection against MnB disease-causing strains...
- Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: a phase 1 randomized-controlled clinical trialHelen S Marshall
Vaccinology and Immunology Research Trials Unit, Women s and Children s Hospital and School of Paediatrics and Reproductive Health, University of Adelaide, North Adelaide, South Australia
Pediatr Infect Dis J 31:1061-8. 2012..A bivalent, recombinant, factor H-binding protein (rLP2086) vaccine was developed to protect against invasive Neisseria meningitidis serogroup B (MnB) in children and adolescents...
- Awareness, anxiety, compliance: community perceptions and response to the threat and reality of an influenza pandemicHelen Marshall
Vacciniology and Immunology Research Trials Unit, Women s and Children s Hospital, Adelaide, Australia
Am J Infect Control 40:270-2. 2012..Reported seasonal influenza vaccine uptake increased from 51.7% in 2007 to 61.4% in 2009, but there was more interest in receiving pandemic vaccine in 2007 (87.5%) than in 2009 (57%)...
- Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 yearsHelen Marshall
University of Adelaide, Adelaide, South Australia, Australia
Vaccine 28:4411-5. 2010..All subjects mounted a vigorous immune response to the challenge indicating the presence of immunological memory to HBV...
- Pandemic influenza and community preparednessHelen Marshall
Paediatric Trials Unit, Women s and Children s Hospital, 72 King William Rd, North Adelaide, South Australia
Am J Public Health 99:S365-71. 2009..We aimed to examine community knowledge about and attitudes toward the threat of pandemic influenza and assess the community acceptability of strategies to reduce its effect...
- Varicella immunisation practice: Implications for provision of a recommended, non-funded vaccineHelen Marshall
Department of Paediatrics, Women s and Children s Hospital, North Adelaide, SA, Australia
J Paediatr Child Health 45:297-303. 2009..The aim of this study was to examine immunisation practice when a vaccine is recommended but not funded by Government...
- Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenicHelen Marshall
School of Paediatrics and Reproductive Health, University of Adelaide and Paediatric Trials Unit, Women s and Children s Hospital, Children, Youth and Women s Health Service, 72 King William Road, North Adelaide SA 5006, Australia
Int J Infect Dis 14:e41-9. 2010..The aim of this study was to evaluate the safety and immunogenicity of DTPa-HBV and Hib vaccines given mixed or separately to 360 healthy infants at 2, 4, and 6 months of age...